MSB
Click for more information
1.03% 98.0¢ mesoblast limited

It has been said many times here, but I'll repeat it:...

  1. sailnyssa
    603 Posts.
    lightbulb Created with Sketch. 292
    clock Created with Sketch.
    19/07/23
    13:45
    Post #: 68866449
    It has been said many times here, but I'll repeat it: Ruxolitinib was approved for sraGvHD 12yrs+ on the basis of an open label single arm trial (Reach 1). Or are you talking about RCT's for completely different indications?
    MSB Price at posting: $1.40 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢ 		Change
0.010(1.03%) 		Mkt cap ! $1.118B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $5.286M 5.409M

Buyers (Bids)

No. Vol. Price($)
3 91218 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 63577 4
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.